Hartig Sean M, Hamilton Mark P, Bader David A, McGuire Sean E
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
Trends Endocrinol Metab. 2015 Dec;26(12):733-745. doi: 10.1016/j.tem.2015.09.006. Epub 2015 Oct 20.
Global expression analyses demonstrate that alterations in miRNA levels correlate with various metabolic diseases. miRNAs regulate central metabolic pathways and thus play vital roles in maintaining organismal energy balance and metabolic homeostasis. Here we highlight novel sequencing technologies used to comprehensively define the target spectrum of miRNAs in metabolic disease that complement recent literature reporting physiologic roles for miRNAs in the regulation of glucose and lipid metabolism in peripheral tissues of animal models of metabolic dysfunction. These emerging technologies help decipher the complexity of the miRNA interactome and enrich our understanding of how miRNAs mediate physiologic effects by targeting a spectrum of gene transcripts simultaneously. miRNA-based therapeutics emerge as a viable strategy for treating metabolic diseases.
全局表达分析表明,miRNA水平的改变与多种代谢性疾病相关。miRNA调节核心代谢途径,因此在维持机体能量平衡和代谢稳态中发挥着至关重要的作用。在此,我们重点介绍了用于全面定义代谢性疾病中miRNA靶标谱的新型测序技术,这些技术补充了最近的文献报道,即miRNA在代谢功能障碍动物模型的外周组织中调节葡萄糖和脂质代谢方面的生理作用。这些新兴技术有助于破解miRNA相互作用组的复杂性,并丰富我们对miRNA如何通过同时靶向一系列基因转录本来介导生理效应的理解。基于miRNA的疗法成为治疗代谢性疾病的一种可行策略。